Tara A. Washington, M.D.
After earning a Bachelor of Science from M.I.T., Dr. Washington received her medical degree from the University of Michigan, Ann Arbor. She continued her training at Henry Ford Hospital in Detroit, MI and Loyola University Hospital in Maywood, IL.
Before arriving in Southern California in 2007, Dr. Washington was a fixture of the Detroit medical community for 13 years, serving as Clinical Chief at several institutions.
Dr. Washington is a sought-after public speaker and medical authority. She’s hosted “The Medical Hour” radio program in Detroit, spoken frequently to community groups and delivered research presentations in South Korea, Qatar and Turkey.
1995, American Board of Radiology Radiation Oncology
1991, National Board of Medical Examiners
1990, M.D., University of Michigan, Ann Arbor, MI
1986, B.S., Massachusetts Institute of Technology, Cambridge, MA
1991 - 1994, Resident, Radiation Oncology, Loyola University Hospital, Maywood, IL
1990 - 1991, Intern, Henry Ford Hospital, Detroit, MI
2018 - present, Radiation Oncologist and Assistant Clinical Professor, Department of Radiation Oncology, City of Hope, Temecula and Wildomar, CA
2007 - 2018, Radiation Oncologist, Vantage Radiation Oncology Center, Wildomar, CA
2007 - 2018, Radiation Oncologist, Vantage Radiation Oncology Center, Redhawk, CA
2004 - 2007, Clinical Chief, Gershenson Radiation Oncology Center, Karmanos Cancer Institute, Detroit, MI
2001 - 2003, Clinical Chief, Sinai-Grace Radiation Oncology Center, Detroit, MI
1996 - 2001, Clinical Chief, North Oakland Radiation Oncology Center, Pontiac, MI
1994 - 1996, Attending Radiation Oncologist, Karmanos Cancer Institute, Multidisciplinary Breast Cancer Team, Detroit, MI
Aref A, Youssef E, Washington TA, Segel M, Grigorian C, Bongers S, Bouman D. The value of Post Lumpectomy Mammogram in the Management of Breast Cancer Patients Presenting With Suspicious Microcalcifications. Cancer Journal Sci Am. 2000, Jan-Feb, 6(1) 25-27.
Newman, LA, Washington, TA: “New Trends in Breast Conservation Therapy” Surgical Clinics of North America 83 (2003) 841 -843.
M.A. Al-Abbadi, T.A. Washington, S.E. Tekyi-Mensah, H.A. Saleh, D.R. Lucas, and C.A. Briston. Wayne State University, Detroit, Michigan. Differential Expression of Her-2/Neu Receptor of Invasive Mammary Carcinoma Between Caucasian and African American Patients in the Detroit Metropolitan Area. Correlation with Overall Survival and Other Prognostic Factors. Breast Cancer Research and Treatment, January 2006. (DOI 10.1007/s10549-005-5149-z)